Capricor Therapeutics (CAPR) SEC Filings & 10K Form

$6.27
+0.07 (+1.13%)
(As of 08:48 AM ET)

Recent Capricor Therapeutics SEC Filings

DateFilerForm TypeView
05/15/2024
4:00 PM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
8:00 AM
Capricor Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
8:25 AM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
8:15 AM
Capricor Therapeutics (Issuer)
COLLIER EARL M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
12:30 PM
Capricor Therapeutics (Issuer)
Musket David B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
3:31 PM
Capricor Therapeutics (Filer)
Form ARS
03/20/2024
4:20 PM
Capricor Therapeutics (Filer)
Form PRE 14A
03/11/2024
7:30 AM
Capricor Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/29/2024
3:06 PM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
2:01 PM
Capricor Therapeutics (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
01/11/2024
8:00 AM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
4:15 PM
Bergmann Anthony (Reporting)
Capricor Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
Krasney Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
Marban Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
Litvack Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
COLLIER EARL M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
Sabar Karimah Es (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
DUNBAR GEORGE W JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
Musket David B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Auwaerter Paul Gisbert (Reporting)
Capricor Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
Gotwals Philip J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
Kelliher Mike (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
3:30 PM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2023
8:25 AM
Bergmann Anthony (Reporting)
Capricor Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2023
3:05 PM
Capricor Therapeutics (Subject)
Nippon Shinyaku Co Ltd (Filed by)
Form SC 13G
10/13/2023
12:59 PM
Capricor Therapeutics (Issuer)
Musket David B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2023
8:15 AM
Capricor Therapeutics (Issuer)
COLLIER EARL M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023
8:15 AM
Capricor Therapeutics (Issuer)
Musket David B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
8:15 AM
Auwaerter Paul Gisbert (Reporting)
Capricor Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
8:15 AM
Capricor Therapeutics (Issuer)
Musket David B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
4:00 PM
Capricor Therapeutics (Subject)
Form FWP
09/29/2023
6:30 AM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2023
5:01 PM
Capricor Therapeutics (Issuer)
Kelliher Mike (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2023
5:03 PM
Capricor Therapeutics (Issuer)
Kelliher Mike (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
8:01 AM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
4:00 PM
Capricor Therapeutics (Issuer)
Litvack Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
7:01 AM
Capricor Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2023
4:09 PM
Capricor Therapeutics (Issuer)
Gotwals Philip J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/24/2023
4:10 PM
Capricor Therapeutics (Issuer)
Gotwals Philip J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
7:35 AM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/13/2023
3:51 PM
Auwaerter Paul Gisbert (Reporting)
Capricor Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
This Apple-like Innovator is Revolutionizing Healthcare (Ad)

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry
07/13/2023
3:53 PM
Auwaerter Paul Gisbert (Reporting)
Capricor Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2023
7:31 AM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2023
4:26 PM
Capricor Therapeutics (Filer)
Form 8-K/A
06/15/2023
4:25 PM
Capricor Therapeutics (Filer)
Form 8-K/A
06/13/2023
4:20 PM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2023
4:15 PM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CAPR) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners